Latency and reactivation of human cytomegalovirus

被引:77
作者
Sissons, JGP [1 ]
Bain, M [1 ]
Wills, MR [1 ]
Sinclair, JH [1 ]
机构
[1] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England
关键词
D O I
10.1053/jinf.2001.0948
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The sequence analysis of herpesviruses suggests they have been evolving with their individual vertebrate hosts for millions of years, and their divergence parallels that of the hosts they infect. Given this time they have been learning to live with their individual hosts, it is not surprising that they have become extremely well adapted to doing so without causing much in the away of obvious disease. A key feature of their strategy for persisting in the host is the ability of all herpesviruses to establish latent infection-a state in which no, or only a very limited set of, viral genes are expressed in cells in which viral DNA persists. The alpha herpesviruses (herpes simplex and varicella zoster virus) establish latency in neuronal cells in sensory ganglia: these are long lived non-dividing cells and the alpha herpesviruses persist in these with expression of only the latency associated transcripts-although the function of these RNA transcripts remains incompletely understood. The principal gamma herpesvirus of humans, Epstein Barr virus (EBV), is latent mainly in B lymphocytes: EBV persistence in B cells is associated with expression of a limited set of viral genes encoding functions necessary for the maintenance of the episomal viral DNA as B cells divide. The mechanism by which the principal beta herpesvirus of humans-human cytomegalovirus (HCMV) persists, is also incompletely understood and the subject of this review. Understanding how HCMV persists has clinical relevance in that its transmission to seronegative recipients might be more easily prevented, and the mechanisms by which it produces disease in the neonate and immunocompromised hosts more easily understood, if we knew more about the cells in which the virus is latent and the away in which it reactivates. (C) 2002 The British Infection Society.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 38 条
[1]   Human cytomegalovirus glycoproteins [J].
Britt, WJ ;
Mach, M .
INTERVIROLOGY, 1996, 39 (5-6) :401-412
[2]   Vital involvement of a natural killer cell activation receptor in resistance to viral infection [J].
Brown, MG ;
Dokun, AO ;
Heusel, JW ;
Smith, HRC ;
Beckman, DL ;
Blattenberger, EA ;
Dubbelde, CE ;
Stone, LR ;
Scalzo, AA ;
Yokoyama, WM .
SCIENCE, 2001, 292 (5518) :934-937
[3]   ADOPTIVE TRANSFER STUDIES DEMONSTRATING THE ANTIVIRAL EFFECT OF NATURAL-KILLER CELLS INVIVO [J].
BUKOWSKI, JF ;
WARNER, JF ;
DENNERT, G ;
WELSH, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (01) :40-52
[4]   Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus:: Meta-analyses of prospective studies [J].
Danesh, J .
AMERICAN HEART JOURNAL, 1999, 138 (05) :S434-S437
[5]   Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus [J].
Fortunato, EA ;
McElroy, AK ;
Sanchez, V ;
Spector, DH .
TRENDS IN MICROBIOLOGY, 2000, 8 (03) :111-119
[6]   Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8+ T lymphocytes in healthy seropositive donors [J].
Gillespie, GMA ;
Wills, MR ;
Appay, V ;
O'Callaghan, C ;
Murphy, M ;
Smith, N ;
Sissons, P ;
Rowland-Jones, S ;
Bell, JI ;
Moss, PAH .
JOURNAL OF VIROLOGY, 2000, 74 (17) :8140-8150
[7]   CYTOMEGALOVIRUS REPLICATES IN DIFFERENTIATED BUT NOT IN UNDIFFERENTIATED HUMAN EMBRYONAL CARCINOMA-CELLS [J].
GONCZOL, E ;
ANDREWS, PW ;
PLOTKIN, SA .
SCIENCE, 1984, 224 (4645) :159-161
[8]   CIRCULATING CYTOMEGALOVIRUS (CMV)-INFECTED ENDOTHELIAL-CELLS IN PATIENTS WITH AN ACTIVE CMV INFECTION [J].
GREFTE, A ;
VANDERGIESSEN, M ;
VANSON, W ;
THE, TH .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (02) :270-277
[9]   Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells [J].
Hahn, G ;
Jores, R ;
Mocarski, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) :3937-3942
[10]  
Johnson DC, 1998, CURR TOP MICROBIOL, V232, P149